Pregabalin Capsule 75 mg (Pregabalin)

Adult dose

This medication should be administered orally, twice a day, regardless of meals, with the total daily dose divided into two doses. Neuropathic pain (peripheral and central): The starting dose is 150 mg per day, which may be increased to a maximum of 600 mg per day at intervals of 3 days to 1 week. Epilepsy: The starting dose is 150 mg per day, which may be increased to a maximum of 600 mg per day at intervals of 1 week. Fibromyalgia: The starting dose is 75 mg.

Child dose

Safety and efficacy data for children under 12 years and adolescents aged 12 to 17 are insufficient, so administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors; if you experience mood changes or unusual behavior while taking it, you should consult your healthcare professional immediately. Patients with an allergy to any of the ingredients in this medication or with certain genetic lactose metabolism disorders should not take it. Diabetic patients should be cautious as weight gain may require adjustments in blood sugar control medications. If you experience facial or oral swelling (angioedema) as an allergic reaction, you should stop taking the medication immediately. Elderly individuals should be especially cautious when starting this medication due to the increased risk of falls or injuries from dizziness or drowsiness. Temporary blurring of vision or changes in vision may occur; if symptoms persist, consult your healthcare professional. Abrupt discontinuation of this medication may result in withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so it should be gradually withdrawn under the guidance of a healthcare professional. Patients with a history of substance abuse may face a higher risk of abuse with this medication; consultation with a healthcare professional before use is advised. Patients with impaired kidney function should have their dosage adjusted and should have their kidney function status monitored regularly. Patients with severe heart disease should use this medication cautiously and should report any symptoms of heart failure to their healthcare provider immediately. Caution is needed when taking this medication with opioid analgesics due to an increased risk of central nervous system depression. Those with respiratory or neurological conditions or the elderly should be cautious as there is a high risk of severe respiratory depression while taking this medication. Pregnant women should avoid this medication during early pregnancy due to the risk of fetal malformation, and women of childbearing age should use effective contraception. Breastfeeding women should consult with their healthcare professional regarding whether to continue taking this medication, as it can be passed to breast milk and affect the infant. Activities requiring alertness, such as driving or operating machinery, should be avoided until dizziness or drowsiness subsides after taking this medication. Serious skin rashes or allergic reactions should prompt immediate discontinuation of the medication and notification to a healthcare provider. In the case of overdose, symptoms may include confusion, drowsiness, depression, and seizures; emergency treatment such as blood dialysis may be needed if necessary. This medication should be kept out of the reach of children and transferring to another container may pose a risk of accidents and degradation of quality.

Serious side effects

Hives, severe swelling, angioedema, chest tightness, difficulty breathing, cold sweats, paleness, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin reactions, shortness of breath or difficulty breathing, asthma attack, abnormal respiratory symptoms accompanied by cough and fever, jaundice, extreme lethargy, hepatic anomalies (jaundice), sudden and severe headaches, thunderclap headaches, seizures,

Mild side effects

Dizziness, drowsiness, confusion, loss of direction sense, irritability, depression, euphoria, decreased libido, insomnia, depersonalization, hyperesthesia, restlessness, agitation, mood swings, emotional blunting, emotional elevation, difficulty finding appropriate terminology, hallucinations, abnormal dreams, increased libido, panic attacks, impulsivity, apathy, ataxia, impaired coordination, equilibrium disorders, memory loss, attention deficits, memory impairment, tremors, speech disturbances, sensory disturbances, sensory loss

This medication should be stored in a tightly closed container to protect it from air and moisture. The recommended storage temperature is between 15°C to 30°C. Proper storage will help maintain the medication's effectiveness and safety over time.

Appearance

A hard capsule with a brown-red upper part and a white lower part containing a white powder.

Package unit

30 capsules/bottle, 100 capsules/bottle